Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    23118444 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy
Condition: Hypercholesterolemia
Interventions: Drug: ETC-1002;   Drug: Placebo
2 Recruiting Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Conditions: Hypercholesterolemia;   Hypertension
Interventions: Drug: ETC-1002;   Drug: Placebo
3 Completed Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients
Condition: Hypercholesterolemia
Interventions: Drug: ETC-1002;   Drug: Ezetimibe

Indicates status has not been verified in more than two years